(Reuters) - "I'm convinced we'll get Xcytrin approved eventually for something because I believe it's an active drug," Miller said in an interview.
"I think our data shows substantial efficacy and I think if they review it in detail and put it in proper context, bringing in advisors who know the disease, that it should meet that standard" , Miller said.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment